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Abstract Proteins of the 14-3-3 family can associate with and/
or modulate the activities of a variety of proteins, such as
protooncogene and oncogene products, Cdc25 phosphatases and
phosphatidylinositol 3-kinase, and thus are implicated in
regulation of signaling pathways and the cell cycle. We report
here that treatment of Jurkat T-cells with an inhibitor of protein
tyrosine phosphatase, pervanadate, induces the association of
14-3-3d with a translational control factor, FKBP12-rapamycin-
associated protein (FRAP), with significant latter’s autophos-
phorylation. Coimmunoprecipitation of various mutants of
FRAP coexpressed with 14-3-3d in COS-7 cells revealed that
14-3-3d binds to the C-terminal side of FRAP at unknown site(s)
different from the predicted binding motifs to date.
z 2000 Federation of European Biochemical Societies.
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1. Introduction
The signal transduction pathways involved in translational
control have remained uncharacterized, although work on the
regulation of gene expression through transcription has made
steady progress. Recently, the immunosuppressor rapamycin,
an inhibitor of G1 cell cycle progression, was used to illumi-
nate a growth factor-regulated signaling pathway in T-cells
that leads to the enhanced translation of a speci¢c subset of
mRNAs which encode ribosomal proteins, translation elonga-
tion factors (eEF1A and eEF2), and an insulin-like growth
factor II [1^3]. The inhibitory e¡ects of rapamycin on cell
cycle progression and translation are based ¢rst upon an as-
sociation of rapamycin with the intracellular protein FKBP12
[4]. This FKBP12-rapamycin complex is a high a⁄nity inhib-
itor of a 289 kDa protein termed FKBP12-rapamycin-associ-
ated protein (FRAP; also called RAFT1/mTOR), a member
of a family of phosphatidylinositol (PI) kinase-related kinases
[5]. The kinase domain of FRAP exhibits homology to the
PI3-kinase p110 subunit and phosphorylates the eukaryotic
translation initiation factor, 4E binding protein 1 (4E-BP1),
and 70 kDa S6 kinase (p70S6k) [6^13]. Although the biological
regulation and function of FRAP are not completely under-
stood, FRAP may be a key enzyme in the translational con-
trol of a growth factor-regulated signaling pathway.
Proteins of the 14-3-3 family have been implicated in regu-
lation of the signaling pathway and cell cycle via their inter-
action with and/or modulation of the activity of Raf [14^17],
Cdc25 phosphatase [18], protein kinase Ca [19], PI3-kinase
[20], Cbl [21], Bcr and Bcr-Abl [22,23], insulin-like growth
factor I receptor and insulin receptor substrate I [24], BAD
[25], and A20 [26]. In this study, we ¢rst demonstrate that
14-3-3d, a predominant isoform among the 14-3-3 proteins
in T-cells [19,27], associates with the autophosphorylated
FRAP in the stimulated T-cells.
2. Materials and methods
2.1. Materials
Phorbol-12-myristate-13-acetate (PMA) and sodium orthovanadate
were purchased from Sigma. Polyclonal antibodies against 14-3-3d
(also called 14-3-3a) (C-17) and anti-FRAP (N-19) were from Santa
Cruz Biotechnology, and the monoclonal anti-FLAG M2 antibodies
and anti-FLAG M2 a⁄nity gel were from Kodak. The horseradish
peroxidase (HRP)-conjugated F(abP)2 fragment of goat anti-rabbit
IgG and anti-mouse IgG were from Zymed, and the HRP-conjugated
F(abP)2 fragment of rabbit anti-goat IgG was from Cappel. All other
reagents were commercial products of the highest grade available.
2.2. Plasmids
pBJ5-FLAG epitope-tagged wild-type FRAP [11], mutant D2357E
FRAP and mutant S2035T FRAP, which has no binding activity as to
the FKBP12-rapamycin complex, were kindly donated by Dr. S.L.
Schreiber (Harvard University, Cambridge, MA, USA). Deletion mu-
tants v44^1336 FRAP and v1703^1996 FRAP were generated by
digestion with SacI and A£III, respectively. 14-3-3d cDNA was cloned
from a human T-cell cDNA library constructed using pcDL-Sra296
vector [28]. Glutathione S-transferase (GST)-14-3-3d fusion protein
was made as follows: BamHI and EcoRI restriction sites were created
at the 5P and 3P end, respectively, of human 14-3-3d cDNA by PCR.
The PCR product was then subcloned into pGEX-2T (Amersham
Pharmacia Biotech).
2.3. Cell culture and cell stimulation
The human leukemic T-cell line, Jurkat, was cultured in RPMI 1640
medium supplemented with 10% fetal bovine serum and antibiotics
(100 U/ml penicillin G and 60 Wg/ml kanamycin). Cells were stimu-
lated with 100 WM pervanadate for 10 min [20] and stimulation was
terminated by washing two times with RPMI 1640 medium. Then the
cells were immediately lysed in 1.0 ml/107 cells of ice-cold lysis bu¡er
(40 mM Tris^HCl bu¡er, pH 7.5, containing 300 mM NaCl, 10 mM
EDTA, 10 mM sodium pyrophosphate, 10 mM NaF, 4 mM Na3VO4,
20 Wg/ml aprotinin and 20 Wg/ml leupeptin). Cells were sonicated for
10 s and then insoluble materials were removed by centrifugation at
15 000Ug at 4‡C for 20 min. COS-7 cells, cultured in Dulbecco’s
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modi¢ed Eagle’s medium containing 10% fetal bovine serum and anti-
biotics, were transiently transfected with plasmid DNAs by electro-
poration using a Bio-Rad Gene Pulser (230 V, 960 WF). After trans-
fection for 48 h, cells were stimulated with 100 WM pervanadate or
500 ng/ml PMA for 10 min. Then the cells were lysed in 0.5 ml/10 cm
dish of ice-cold lysis bu¡er for 15 min and then centrifuged
(15 000Ug, for 15 min at 4‡C). The supernatant materials were then
used for analyses.
2.4. Coimmunoprecipitation of FRAP with 14-3-3d and Western
immunoblotting
Cell lysates (1 ml) were mixed with 1 Wg of antibodies for 3 h at
4‡C, and then incubated with 20 Wl of 50% protein G Sepharose beads
for an additional 2 h. The immunoprecipitates were washed four times
with lysis bu¡er, and then eluted with 3ULaemmli’s sodium dodecyl
sulfate (SDS) sample bu¡er with boiling for 10 min. In some experi-
ments, the cell lysates (0.5 ml) were immunoprecipitated with 20 Wl of
anti-FLAG M2 a⁄nity gel with incubation for 3 h at 4‡C. The im-
munoprecipitates were subjected to SDS^polyacrylamide gel electro-
phoresis (SDS^PAGE) (4^20% gradient) under reducing conditions
and then electrotransferred onto polyvinylidene di£uoride (PVDF)
membranes (Millipore). The membranes were then incubated with
the indicated primary antibodies, followed by HRP-conjugated sec-
ondary antibodies. Bound antibodies were visualized with an ECL
detection system (Amersham) according to the manufacturer’s instruc-
tions.
2.5. Kinase assay
Autophosphorylation of the immunoprecipitates of FRAP was car-
ried out for 20 min at 30‡C in 25 mM HEPES bu¡er, pH 7.7, con-
taining 50 mM KCl, 10 mM MgCl2, 0.1% NP-40, 20% glycerol, 1 mM
DTT, 100 WM ATP and 1 WCi of [Q-32P]ATP, and the reactions were
terminated by adding 3USDS sample bu¡er. The reaction products
were then separated by SDS^PAGE and transferred to a PVDF mem-
brane, and then 32P incorporation into the FRAP and various mu-
tants was quantitated with a Bio Imaging Analyzer BAS1500 (Fuji
Photo Film).
3. Results and discussion
3.1. Association of FRAP with 14-3-3d in T-cells after
stimulation by pervanadate
An intracellular stimulatory regulator for FRAP has not
been detected so far, although inhibitory regulators have
been well characterized [4,6,11]. In the studies on T-cell stim-
ulation by a tyrosine phosphatase inhibitor, pervanadate,
which rapidly induces a series of proximal T-cell activation
events closely resembling those induced by T-cell antigen
[29,30], we found 14-3-3d associates with PI3-kinase as re-
ported [20,21] as well as FRAP as a novel binding protein,
the C-terminal domain sequence of 660 amino acids of FRAP
exhibiting a homology to mammalian PI3-kinase (about 40%
identity), and several other known PI kinases, such as yeast
PI3-kinase, VPS34 and PIKI [12].
Jurkat cells were stimulated with pervanadate for 10 min,
and then cell lysates were immunoprecipitated with anti-14-3-
3d or anti-FRAP antibodies. The precipitates were then sub-
jected to SDS^PAGE followed by Western immunoblotting.
As shown in Fig. 1A, a protein band immunoreactive with
anti-FRAP IgG was detected for the immunoprecipitates of
cell lysates with anti-14-3-3d IgG, but not for those with non-
immunized IgG. Conversely, a protein band immunoreactive
with anti-14-3-3d IgG was observed for the immunoprecipi-
tates with anti-FRAP IgG (Fig. 1B). The association between
FRAP and 14-3-3d in T-cell lysates without activation by
pervanadate, however, was very low.
To con¢rm the signal-dependent association of FRAP with
14-3-3d in other cells, FRAG-tagged FRAP was coexpressed
in COS-7 cells with 14-3-3d, and after 48 h, the cells were
treated with 100 WM pervanadate or 500 ng/ml of PMA for
10 min. Then cell lysates were immunoprecipitated with anti-
FLAG M2 a⁄nity gel. After Western blotting of the immu-
noprecipitates, 14-3-3d, which was coimmunoprecipitated with
FRAP, was detected with the anti-14-3-3d antibodies.
Although the association between FRAP and 14-3-3d was
low in the unstimulated COS-7 cells, the FRAP/14-3-3d asso-
ciation in the cells stimulated by pervanadate was signi¢cantly
enhanced (Fig. 2). PMA, however, did not induce the FRAP/
14-3-3d association, although the mechanism underlying this
¢nding has not been clari¢ed yet.
To determine whether or not the association of FRAP with
14-3-3d is direct, we treated nitrocellulose membranes contain-
ing the electrophoresed FRAG-tagged FRAP immunoprecipi-
tates with recombinant GST-14-3-3d protein or GST as a
control for 3 h, and then detected the binding of 14-3-3d
with anti-GST monoclonal antibodies. GST-14-3-3d but not
the control GST protein bound to the FRAP (Fig. 3). This
indicates that 14-3-3d most likely binds directly to FRAP.
3.2. Association of 14-3-3d with the autophosphorylated FRAP
and the binding domain of FRAP for 14-3-3d
In a mitogen-stimulated signaling pathway in T-cells, the
autophosphorylation of FRAP accompanies the activation
of FRAP kinase, which phosphorylates translation factors
[12]. We analyzed the e¡ect of the autophosphorylation of
FRAP on the association of 14-3-3d with FRAP. As a neg-
Fig. 1. Association of FRAP with 14-3-3d in human T-cells. Jurkat
cell lysates of unstimulated cells (3) or cells after stimulation by
pervanadate (+) were immunoprecipitated with anti-14-3-3d or nor-
mal control rabbit IgG (A), and anti-FRAP or normal goat IgG
(B). The immunoprecipitates were resolved by 4^20% gradient SDS^
PAGE and then transferred to PVDF membranes. The blots were
probed with anti-FRAP and anti-14-3-3d antibodies, and visualized
with ECL. Arrows and arrowheads indicate FRAP and 14-3-3d, re-
spectively.
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ative control in an investigation of the function of FRAP
kinase and its autophosphorylation, mutant D2357E FRAP,
which has no kinase and autophosphorylation activities but
retains binding activity as to FKBP12-rapamycin, was used.
FLAG-tagged wild-type FRAP, mutant D2357E FRAP and
the N-terminal side-deletion mutant, v44^1336 FRAP, were
coexpressed in COS-7 cells with 14-3-3d, and after 48 h, the
cells were treated with 100 WM pervanadate for 10 min. Im-
munoprecipitates of the cell lysates with anti-FLAG M2 af-
¢nity gel were then subjected to an in vitro kinase assay (Fig.
4). Pervanadate induced the association of 14-3-3d with wild-
type FRAP, together with a marked increase in the autophos-
phorylation of FRAP. Pervanadate also stimulated the 14-3-
3d/v44^1336 FRAP association and the latter’s autophosphor-
ylation, the association and autophosphorylation being al-
most equivalent to those observed for the cells expressing
the wild-type FRAP and 14-3-3d. On the other hand, the
D2357E FRAP/14-3-3d association induced by pervanadate
was signi¢cantly lower than the wild-type FRAP/14-3-3d as-
sociation, and no autophosphorylation of D2357E FRAP was
observed. Since autophosphorylation of FRAP is accompa-
nied by the kinase function of FRAP that leads to activation
of p70S6k and 4E-BP1 [12], autophosphorylation of FRAP
accompanied by 14-3-3d association may be an important
process in a T-cell activation by pervanadate. The results sug-
gest that 14-3-3d predominantly binds to the autophosphory-
lation site(s) on the C-terminal side of FRAP, although the
binding and autophosphorylation site(s) have not been clari-
¢ed yet. This speculation is supported by the previous ¢ndings
that the interaction of 14-3-3 with signaling proteins is medi-
ated by the recognition of phosphoserine [31^33]. On the oth-
er hand, our ¢ndings also indicate that 14-3-3d also binds
partly to the non-autophosphorylation site(s) of FRAP, be-
cause FRAP D2357E bound to 14-3-3d to a limited extent
(Fig. 4).
Fig. 2. Association of FRAP with 14-3-3d in COS-7 cells. COS-7
cells were transiently co-transfected with pBJ5-FLAG-tagged wild-
type FRAP (wFRAP) and pcDL-SRa296-14-3-3d (5 and 7.5 Wg of
DNA, respectively), or the vectors. After transfection for 48 h, the
cells were stimulated with 100 WM pervanadate or 500 ng/ml PMA
for 10 min. Cell lysates of the stimulated or unstimulated (3) cells
were immunoprecipitated with anti-FLAG M2 a⁄nity gel. The im-
munoprecipitates were resolved by 4^20% gradient SDS^PAGE and
then transferred to PVDF membranes. The blots were probed with
anti-FLAG and anti-14-3-3d antibodies, and visualized with ECL.
Arrows and arrowheads indicate FRAP and 14-3-3d, respectively.
Fig. 3. Direct interaction of 14-3-3d to FRAP. COS-7 cells were
transiently transfected with pBJ5-FLAG-tagged wild-type FRAP
(wFRAP) or the empty vector (5 Wg of DNA) for 48 h, and then
stimulated with 100 WM pervanadate for 10 min. Cell lysates of the
stimulated (+) or unstimulated (3) cells were immunoprecipitated
with anti-FLAG M2 a⁄nity gel. The immunoprecipitates were sub-
jected to 4^20% gradient SDS^PAGE and then transferred to a ni-
trocellulose membrane. The membrane was overlaid with 5 Wg/ml of
recombinant GST-14-3-3d or GST, and the binding was detected
with anti-GST antibodies. The membrane was then stripped and re-
probed with anti-FLAG antibodies. The bound antibodies were vi-
sualized with ECL.
Fig. 4. Autophosphorylation of FRAP and its variants, and their
association with 14-3-3d after stimulation by pervanadate. COS-7
cells were transiently co-transfected with pBJ5-FLAG-tagged wild-
type FRAG (wFRAP), FRAP variants D2357E and v44^1336, or
the empty vector (each 7.5 Wg of DNA), and pcDL-SRa296-14-3-3d
(5 Wg of DNA), for 48 h. After transfection, the cells were stimu-
lated with 100 WM pervanadate for 10 min. Cell lysates of the
unstimulated (3) or pervanadated stimulated (+) cells were
immunoprecipitated with anti-FLAG M2 a⁄nity gel. The immuno-
precipitates were incubated with [Q-32P]ATP for 20 min at 30‡C, and
the reactions were terminated by adding 3USDS sample bu¡er. The
reaction products were resolved by 4^20% gradient SDS^PAGE and
transferred to PVDF membranes, and then 32P incorporation into
wFRAP and its mutants, D2357E and v44^1336, was detected with
a BAS1500 (A). FLAG-tagged wFRAP, D2357E and v44^1336, in
the immunoprecipitates (B) and 14-3-3d in the immunoprecipitates
(C) were quanti¢ed by immunoblotting with anti-FLAG and 14-3-
3d antibodies, respectively. Arrows indicate wFRAP and FRAP var-
iants, and arrowhead indicates 14-3-3d.
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Based on the results of analysis of the interaction of 14-3-3
with Raf-1 and Cdc25, the sequences, RSxpSxP and RxY/
FxpSP (single-letter amino acid code, where x is any amino
acid and pS is a phosphoserine residue), are proposed for 14-
3-3 binding motifs [31^33]. Although FRAP does not contain
the exact motifs, it has the sequence, R1890SISLS1895, which is
similar to the putative binding motif, RSxpSxP, but the C-
terminal proline is substituted by serine, on the N-terminal
adjacent region to the FKBP12-rapamycin binding site of
FRAP. In order to determine whether or not this motif in
FRAP plays a role in the association with 14-3-3d, truncation
mutant, v1703^1996 FRAP, in which the area encoding this
sequence was deleted, was constructed. As assessed by FRAP
coexpression assaying of COS-7 cells with 14-3-3d described in
Fig. 2, the v1703^1996 FRAP/14-3-3d association after stim-
ulation by pervanadate was almost equivalent to the wild-type
FRAP/14-3-3d association (data not shown). We further ex-
amined the possibility of FRAP/14-3-3d association at the
FKBP12-rapamycin binding site, S2035, because both the
protein kinase activity and autophosphorylation of FRAP
are inhibited by FKBP12-rapamycin [11]. However, S2035T
FRAP/14-3-3d association in COS-7 cells after stimulation by
pervanadate was also equivalent to the wild-type FRAP/14-3-
3d association (data not shown). Further de¢nition through
deletion and mutation of the C-terminal side domain of
FRAP will facilitate investigations to identify the exact bind-
ing site(s) for 14-3-3d, and to analyze the mechanism of stim-
ulation of FRAP kinase.
In studies on immunosuppressor rapamycin, it was sug-
gested that FRAP promotes the phosphorylation of S6 via
p70S6k activation, and releases 4E-BP1 from eIF-4E through
the phosphorylation of 4E-BP1, and that FRAP regulates the
translation to proteins [34^36]. In addition, biological evi-
dence that the 14-3-3 protein positively regulates rapamycin-
sensitive signaling in budding yeast has recently been reported
[37], although the target of the 14-3-3 protein has not been
clari¢ed yet. This biological evidence strongly supports our
¢nding of an interaction between 14-3-3d and FRAP and
suggests the biological signi¢cance of the 14-3-3d/FRAP asso-
ciation. In the present study, we demonstrated the 14-3-3d/
FRAP association. The other isoforms of 14-3-3 family pro-
teins may also bind to FRAP in various cells because of high
structural similarity among 14-3-3 family proteins. Further
studies on the role of 14-3-3d in FRAP-mediated translational
regulation in T-cells are now in progress.
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